UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,961,836 | -70.3% | 292,375 | -49.3% | 0.00% | -50.0% |
| Q2 2023 | $6,602,691 | +958.9% | 576,151 | +1761.0% | 0.00% | – |
| Q1 2023 | $623,514 | -44.2% | 30,959 | -37.2% | 0.00% | -100.0% |
| Q4 2022 | $1,118,198 | +406.0% | 49,325 | +317.9% | 0.00% | – |
| Q3 2022 | $221,000 | -52.4% | 11,804 | -52.6% | 0.00% | – |
| Q2 2022 | $464,000 | -86.3% | 24,927 | -86.7% | 0.00% | – |
| Q1 2022 | $3,378,000 | -44.7% | 186,928 | -36.5% | 0.00% | -100.0% |
| Q4 2021 | $6,109,000 | +0.5% | 294,582 | +55.1% | 0.00% | 0.0% |
| Q3 2021 | $6,077,000 | -36.6% | 189,884 | -39.0% | 0.00% | -50.0% |
| Q2 2021 | $9,589,000 | +52.6% | 311,332 | +66.9% | 0.00% | +33.3% |
| Q1 2021 | $6,285,000 | +78.3% | 186,568 | +91.2% | 0.00% | +50.0% |
| Q4 2020 | $3,524,000 | +12.4% | 97,561 | +14.6% | 0.00% | 0.0% |
| Q3 2020 | $3,134,000 | -54.5% | 85,100 | -44.3% | 0.00% | -60.0% |
| Q2 2020 | $6,882,000 | +224.3% | 152,747 | +241.5% | 0.01% | +150.0% |
| Q1 2020 | $2,122,000 | +22.8% | 44,726 | +85.5% | 0.00% | -33.3% |
| Q4 2019 | $1,728,000 | +493.8% | 24,109 | +225.8% | 0.00% | – |
| Q3 2019 | $291,000 | -71.8% | 7,399 | -44.0% | 0.00% | -100.0% |
| Q2 2019 | $1,032,000 | +210.8% | 13,207 | +137.5% | 0.00% | +100.0% |
| Q1 2019 | $332,000 | +48.2% | 5,561 | -41.6% | 0.00% | 0.0% |
| Q1 2018 | $224,000 | +16.7% | 9,525 | -17.9% | 0.00% | 0.0% |
| Q4 2015 | $192,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |